Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats

Highlights • Examined whether candesartan can ameliorate arsenic-induced vascular disorders. • Arsenic caused systemic hypertension & also enhanced AngII-induced blood pressure. • Arsenic elevated AngII & TGF-β levels; up-regulated aortic AT1 & TβRII receptors. • Also increased transduce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology (Amsterdam) 2016-12, Vol.374, p.29-41
Hauptverfasser: Khuman, Maibam Wanta, Harikumar, Sankaran Kutty, Sadam, Abdul, Kesavan, Manickam, Susanth, Vattaparambil Sukumaran, Parida, Subhashree, Singh, Karam Pal, Sarkar, Souvendra Nath
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Examined whether candesartan can ameliorate arsenic-induced vascular disorders. • Arsenic caused systemic hypertension & also enhanced AngII-induced blood pressure. • Arsenic elevated AngII & TGF-β levels; up-regulated aortic AT1 & TβRII receptors. • Also increased transducers of MAPK & TGF-β pathways, aortic collagen & thickness. • Candesartan reduced arsenic-induced functional, biochemical & structural changes.
ISSN:0300-483X
1879-3185
DOI:10.1016/j.tox.2016.11.015